First Affiliated Hospital Of Zhejiang University
Clinical trials sponsored by First Affiliated Hospital Of Zhejiang University, explained in plain language.
-
Promising chemo cocktail shows hope for AML patients under 60
Disease control CompletedThis study tested a three-drug chemotherapy combination (cladribine, homoharringtonine, and cytarabine) in 65 adults under 60 with newly diagnosed acute myeloid leukemia (AML). The goal was to see how well it wiped out leukemia cells and how safe it was. Results tracked complete …
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Stents show promise for rare gut artery tear
Disease control CompletedThis study tested the safety and effectiveness of using stents (small mesh tubes) to treat a tear in the main artery supplying the gut. 136 patients with this rare condition were treated and followed for 12 months. The goal was to see how many needed a second procedure and to che…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can a heart drug save kidneys in septic shock surgery?
Disease control CompletedThis study looked at whether the drug dobutamine helps people with septic shock who are having surgery. Septic shock is a life-threatening condition where blood pressure drops dangerously low. The researchers wanted to see if dobutamine could reduce kidney injury, organ failure, …
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can magnetic pulses sharpen a bipolar brain?
Symptom relief CompletedThis study tested whether a combination of two brain stimulation techniques—repetitive transcranial magnetic stimulation (rTMS) and transcranial alternating current stimulation (tACS)—could improve cognitive function in people with bipolar disorder who are in remission. 116 parti…
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Zapping the back of the brain to lift teen depression?
Symptom relief CompletedThis study tested a new way to use repetitive transcranial magnetic stimulation (rTMS) to treat depressive episodes in 40 adolescents with bipolar disorder. Instead of the usual front-brain target, researchers stimulated the visual cortex at the back of the brain, aiming to affec…
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Zapping the brain to lift bipolar depression: new device shows promise
Symptom relief CompletedThis study tested a non-invasive brain stimulation technique called temporal interference stimulation (TI) to improve depression in people with bipolar disorder. Thirty-six participants received 10 sessions over two weeks, targeting a deep brain area linked to pleasure and reward…
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Could a magnetic helmet boost brainpower in bipolar patients?
Symptom relief CompletedThis study tested whether a non-invasive brain stimulation technique called repetitive transcranial magnetic stimulation (rTMS) could improve cognitive function in 82 people with stable bipolar disorder. Participants received task-activated rTMS while doing cognitive training. Th…
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Shingles study aims to predict who gets lingering nerve pain
Knowledge-focused CompletedThis study looked at 151 adults with shingles to find clues that might predict who will develop lasting nerve pain (postherpetic neuralgia). Researchers collected blood samples and health information at the start and checked for pain three months later. The goal was to create a r…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC